Physician profile
John W Johnson
NPI 1982749164
$792.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $14.35 · 2022: $126.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $312.73 | 2019 | |
| Intuitive Surgical, INC. | $99.23 | 2022 | |
| Dendreon Pharmaceuticals LLC | $91.68 | 2019 | |
| Boston Scientific Corporation | $72.76 | 2019-2020 | |
| Abbvie INC. | $61.10 | 2019 | |
| Janssen Biotech, INC. | $42.85 | 2019 | |
| Pfizer INC. | $29.82 | 2019 | |
| Laborie Medical Technologies Corp. | $26.50 | 2022 | |
| Metuchen Pharmaceuticals | $25.24 | 2019 | |
| Blue Earth Diagnostics | $17.05 | 2019 | |
| Mission Pharmacal Company | $13.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.